相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model
Yanling Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool
Martina Mandarano et al.
FRONTIERS IN IMMUNOLOGY (2020)
Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells
Azubuike Peter Ebokaiwe et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Role of NF-kB RelB in Aryl Hydrocarbon Receptor-Mediated Ligand Specific Effects
Yasuhiro Ishihara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma
Wakana Yamasuge et al.
CANCER SCIENCE (2019)
Synthesis and in vivo antitumor evaluation of an orally active potent phosphonamidate derivative targeting IDO1/IDO2/TDO
Xi Feng et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Immune control by amino acid catabolism during tumorigenesis and therapy
Henrique Lemos et al.
NATURE REVIEWS CANCER (2019)
Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS-Driven Sporadic Pancreatic Cancers
Avinoam Nevler et al.
CLINICAL CANCER RESEARCH (2019)
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation (vol 26, pg 357, 2014)
Richard Metz et al.
INTERNATIONAL IMMUNOLOGY (2019)
Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation
Yuying Liu et al.
CANCER CELL (2018)
Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities
Jae Eun Cheong et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Targeting the IDO1 pathway in cancer: from bench to bedside
Ming Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling
Yasuko Yamamoto et al.
SCIENTIFIC REPORTS (2018)
Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2
Felicita F. Jusof et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2017)
Learning from other diseases: protection and pathology in chronic fungal infections
Teresa Zelante et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2)
Ute F. Rohrig et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice
Nathaniel S. Woodling et al.
BRAIN (2016)
Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase
Rene Fuertig et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients
Jayakumar Hascitha et al.
CLINICAL BIOCHEMISTRY (2016)
High l-Trp affinity of indoleamine 2,3-dioxygenase 1 is attributed to two residues located in the distal heme pocket
Hajime J. Yuasa
FEBS JOURNAL (2016)
IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism
Lauren M. F. Merlo et al.
JOURNAL OF IMMUNOLOGY (2016)
Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus
Alexandra K. Brooks et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest
Joerg C. Schefold et al.
RESUSCITATION (2016)
Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD plus and inhibits in vivo tumor growth
Yanling Liu et al.
ONCOTARGET (2016)
Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes
Reza B. Jalili et al.
PLOS ONE (2016)
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells
Olga Novikov et al.
MOLECULAR PHARMACOLOGY (2016)
Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable
Hajime J. Yuasa et al.
FEBS JOURNAL (2015)
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
Lijie Zhai et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis
Roberta Mancuso et al.
PLOS ONE (2015)
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
Ivan Theate et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Inhibition of De Novo NAD+ Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
Krishna S. Tummala et al.
CANCER CELL (2014)
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
Richard Metz et al.
INTERNATIONAL IMMUNOLOGY (2014)
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes
Maria Teresa Pallotta et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells
Sara Trabanelli et al.
JOURNAL OF IMMUNOLOGY (2014)
Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration
Xiao-Qian Liu et al.
LEUKEMIA & LYMPHOMA (2014)
IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype
Alexander Lee et al.
PLOS ONE (2014)
Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease
Amos A. Fatokun et al.
AMINO ACIDS (2013)
Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation
Christoph F. A. Vogel et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2
Supun M. Bakmiwewa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation
Feng Qian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
Michael Platten et al.
CANCER RESEARCH (2012)
Studies on Tissue and Cellular Distribution of Indoleamine 2,3-Dioxygenase 2: The Absence of IDO1 Upregulates IDO2 Expression in the Epididymis
Masakazu Fukunaga et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Association of a polymorphism in the indoleamine-2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
A. K. Smith et al.
MOLECULAR PSYCHIATRY (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes
B. K. K. Lo et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Pharmacological Effects of Exogenous NAD on Mitochondrial Bioenergetics, DNA Repair, and Apoptosis
Maria Pittelli et al.
MOLECULAR PHARMACOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO)
Juliana Croitoru-Lamoury et al.
PLOS ONE (2011)
Consequences of AhR Activation in Steady-State Dendritic Cells
Tom Simones et al.
TOXICOLOGICAL SCIENCES (2011)
Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2
Christopher Jonathan Daraius Austin et al.
AMINO ACIDS (2010)
1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan
Hajime J. Yuasa et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2010)
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Joshua D. Mezrich et al.
JOURNAL OF IMMUNOLOGY (2010)
Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells
Ting Sun et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer
Yuzo Suzuki et al.
LUNG CANCER (2010)
An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis
Francisco J. Quintana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Functional and phenotypic effects of AhR activation in inflammatory dendritic cells
Jaishree Bankoti et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
Stefan Loeb et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase
Silvia K. Schmidt et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
Tomoko Inaba et al.
GYNECOLOGIC ONCOLOGY (2009)
Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
Agnieszka K. Witkiewicz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host
Teresa Zelante et al.
MICROBES AND INFECTION (2009)
Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase
Christoph F. A. Vogel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: Its association with disease progression and survival
Kazuhiko Ino et al.
CLINICAL CANCER RESEARCH (2008)
Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection
Agnes Witkiewicz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Evolution of vertebrate indoleamine 2,3-dioxygenases
Hajime Julie Yuasa et al.
JOURNAL OF MOLECULAR EVOLUTION (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer
Takafumi Nakamura et al.
CANCER SCIENCE (2007)
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells
Antonio Curti et al.
BLOOD (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation
Adriano Boasso et al.
CURRENT DRUG METABOLISM (2007)
Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients
Georg Weinlich et al.
DERMATOLOGY (2007)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
Tryptophan degradation in patients with gynecological cancer correlates with immune activation
K Schroecksnadel et al.
CANCER LETTERS (2005)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer
A Huang et al.
BRITISH JOURNAL OF CANCER (2002)
分享论文
